home / stock / hrtx / hrtx news


HRTX News and Press, Heron Therapeutics Inc. From 05/02/19

Stock Information

Company Name: Heron Therapeutics Inc.
Stock Symbol: HRTX
Market: NASDAQ
Website: herontx.com

Menu

HRTX HRTX Quote HRTX Short HRTX News HRTX Articles HRTX Message Board
Get HRTX Alerts

News, Short Squeeze, Breakout and More Instantly...

HRTX - Heron: In The Middle Of Every Difficulty Lies Opportunity

You don't make money when you buy stocks. And you don't make money when you sell stocks. You make money by waiting - The Dhando Investor (Mohnish Pabrai) According to Integrated BioSci Investing, being "opportunistic" is one of the requisites to successful capital allocation. Stellar inves...

HRTX - SSNC and PBI among premarket losers

Heron Therapeutics (NASDAQ: HRTX )  -24%  after FDA rejects application for pain med HTX-011. More news on: Heron Therapeutics, Inc., Nabriva Therapeutics plc, CM Seven Star Acquisition Corporation, Stocks on the move, Read more ...

HRTX - Earnings movers dominate premarket gainers

Staffing 360 Solutions (NASDAQ: STAF ) +22%  on Q1 earnings . More news on: Staffing 360 Solutions, Inc., Nu Skin Enterprises, Inc., Enphase Energy, Inc., Stocks on the move, Read more ...

HRTX - ClearBridge Large Cap Growth ESG Strategy Portfolio Manager Commentary Q1 2019

Read more ...

HRTX - FDA rejects Heron's application for pain med HTX-011; shares down 1% premarket

Heron Therapeutics (NASDAQ: HRTX ) has received a CRL from the FDA regarding its marketing application for HTX-011 for the management of postoperative pain. More news on: Heron Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...

HRTX - Heron Therapeutics Receives Complete Response Letter For HTX-011 For The Management Of Postoperative Pain

SAN DIEGO , May 1, 2019 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that ...

HRTX - FDA Decision Imminent On Heron's Pain Therapy Candidate

We think Heron ( HRTX ) has a very good chance of approval by the FDA by the April 30, 2019 due date for its non-opioid pain med HTX-011. This would be good for society in our fight against the opioid crisis. Furthermore, it could be rewarding for investors too, since this derisking event if t...

HRTX - Eyes On Apple, Uber, F8 And Avengers (Stocks To Watch Podcast)

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you c...

HRTX - Stocks To Watch: Eyes On Apple, Uber, F8 And Avengers

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. The U.S. will send a high-level delegation to Beijing next week as trade negotiatio...

HRTX - Key events next week - healthcare (Part 1)

Noteworthy events during the week of April 28 - May 4 for healthcare investors. More news on: Catalyst Biosciences, Inc., Aldeyra Therapeutics, Inc., BioTime, Inc., Healthcare stocks news, , Read more ...

Previous 10 Next 10